An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN

  • Sebastian M Schellong, Sylvia Haas, Andreas Greinacher, Uta Schwanebeck, Christian Sieder, Claudia Abletshauser, Peter Bramlage, Hanno Riess
  • Expert Opinion on Pharmacotherapy, October 2010, Informa Healthcare
  • DOI: 10.1517/14656566.2010.521498

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Peter Bramlage